Identification and Characteristics of Time-Related Shifts in Suicide-Related Event Frequency During Smoking Cessation Treatment with Varenicline.

about

Onset timing of statin-induced musculoskeletal adverse events and concomitant drug-associated shift in onset timing of MAEs

P2860

Q59133164-BF0F23A2-E552-4B1B-8F00-E7F000B8A287

P2860

Identification and Characteristics of Time-Related Shifts in Suicide-Related Event Frequency During Smoking Cessation Treatment with Varenicline.

Item

http://www.wikidata.org/entity/Q41035791

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Identification and Characteris ...... on Treatment with Varenicline.

@en

type

Item

label

Identification and Characteris ...... on Treatment with Varenicline.

@en

prefLabel

Identification and Characteris ...... on Treatment with Varenicline.

@en

P1476

Identification and Characteris ...... on Treatment with Varenicline.

@en

P2093

Daisuke Kobayashi

http://www.w3.org/2001/XMLSchema#string

Haruna Wakiyama

http://www.w3.org/2001/XMLSchema#string

Kousuke Ohara

http://www.w3.org/2001/XMLSchema#string

Naoko Inoue

http://www.w3.org/2001/XMLSchema#string

Sachihiko Numajiri

http://www.w3.org/2001/XMLSchema#string

Shigeru Ohshima

http://www.w3.org/2001/XMLSchema#string

Shinji Oshima

http://www.w3.org/2001/XMLSchema#string

P2860

A curated and standardized adverse drug event resource to accelerate drug safety research

Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis

Assessment of the Risk of Suicide-Related Events Induced by Concomitant Use of Antidepressants in Cases of Smoking Cessation Treatment with Varenicline and Assessment of Latent Risk by the Use of Varenicline

Psychiatric diagnoses as contemporaneous risk factors for suicide attempts among adolescents and young adults: developmental changes.

Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.

Major depressive disorder and smoking relapse among adults in the United States: a 10-year, prospective investigation

A Review of Varenicline's Efficacy and Tolerability in Smoking Cessation Studies in Subjects with Schizophrenia.

Annual healthcare spending attributable to cigarette smoking: an update

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial.

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

P304

920-926

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/IJMS.19877

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hayato Akimoto

Mitsuyoshi Okita

Akio Negishi

P577

2017-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28924362

http://www.w3.org/2001/XMLSchema#string

P921

Bunuh diri

P932

5599914

http://www.w3.org/2001/XMLSchema#string

Identification and Characteristics of Time-Related Shifts in Suicide-Related Event Frequency During Smoking Cessation Treatment with Varenicline.

about

P2860

P2860

Identification and Characteristics of Time-Related Shifts in Suicide-Related Event Frequency During Smoking Cessation Treatment with Varenicline.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932